This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Macau University of Science and Technology. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- MO, MO (2016)
- Taipa, CN (2017 - 2018)
Company Filing History:
Years Active: 2016-2018
Title: Innovations in Cancer Treatment by Inventor Lian Xiang Luo
Introduction
Lian Xiang Luo is an innovative inventor based in Taipa, China. With a remarkable portfolio of three patents, he has made significant contributions to the field of cancer treatment. His work primarily focuses on targeting oncogenic pathways that contribute to various cancers, offering promising therapeutic avenues for affected patients.
Latest Patents
One of Lian Xiang Luo's latest patents is related to a ROS1 inhibitor and its application in treating cancer. This invention details the administration of a compound designed with specific structural components, including a quinoline moiety in the backbone and at least one tertiary amine moiety in the side chain. The innovative design facilitates interaction with the ROS1 kinase domain, particularly in the hinge region, proving beneficial for patients suffering from ROS1-dependent cancers.
Additionally, his patent on an oncogenic ROS1 and ALK kinase inhibitor outlines a compound suitable for treating non-small cell lung cancer (NSCLC). The structural components of this compound, which includes a quinoline backbone and a phenyl-containing side chain with hydrophobic attributes, enable effective targeting of cancer cells harboring abnormalities in the ROS1 or ALK genes. This work holds promise for numerous patients dealing with these specific cancer types.
Career Highlights
Lian Xiang Luo's career at the Macau University of Science and Technology has been marked by his dedication to advancing cancer research. His groundbreaking inventions contribute not only to scientific knowledge but also to practical advancements in cancer therapies. The focus on developing targeted therapies reflects a growing trend in modern oncology to personalize treatment options for better patient outcomes.
Collaborations
Luo works alongside esteemed colleagues such as Xiao Jun Yao and Lai Han Leung. Collaborations within his research team have fostered an environment of innovation, enhancing the potential for groundbreaking discoveries in the field of cancer treatment.
Conclusion
Lian Xiang Luo's contributions to oncology through his patents exemplify the intersection of cutting-edge science and practical application. His inventions are poised to transform treatment approaches for cancer patients, especially those with ROS1-dependent conditions. With ongoing research and collaborative efforts, the future looks bright for innovations arising from his work.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile